Search Results - "Sdayoor, Inbal"

Anti-CD19 chimeric antigen receptor T-cell therapy has less efficacy in Richter transformation than in de novo large B-cell lymphoma and transformed low-grade B-cell lymphoma by Benjamini, Ohad, Fried, Shalev, Shouval, Roni, Flynn, Jessica R, Beyar-Katz, Ofrat, Leslie, Lori A, Zucherman, Tsilla, Yerushalmi, Ronit, Shem-Tov, Noga, Palomba, Maria Lia, Danylesko, Ivetta, Sdayoor, Inbal, Malka, Hila, Itzhaki, Orit, Suh, Hyung, Devlin, Sean M, Marcus, Ronit, Dahi, Parastoo B, Jacoby, Elad, Shah, Gunjan L, Sauter, Craig S, Ip, Andrew, Perales, Miguel-Angel, Nagler, Arnon, Shimoni, Avichai, Scordo, Michael, Avigdor, Abraham

“…The activity of anti-CD19 CAR T cell therapy in chronic lymphocytic leukemia (CLL) with Richter's transformation (RT) to aggressive large B cell lymphoma…”
Get full text

P1400: THREE YEARS OUTCOMES OF PRIMARY MEDIASTINAL B CELL LYMPHOMA PATIENTS FOLLOWING ANTI CD19 CAR‐T CELL THERAPY ‐ A SINGLE CENTER EXPERIENCE by Geva, Mika, Fried, Shalev, Itzhaki, Orit, Shem‐Tov, Noga, Danylesko, Ivetta, Yerushalmi, Ronit, Marcus, Ronit, Sdayoor, Inbal, Shapira‐Frommer, Ronnie, Kedmi, Meirav, Shouval, Roni, Nagler, Arnon, Shimoni, Avichai, Avigdor, Abraham

Get full text

High Response Rates Following Point-of-Care Anti-CD19 CAR T-Cell Therapy in Adults with Relapsed/Refractory Acute B Lymphoblastic Leukemia by Fried, Shalev, Danylesko, Ivetta, Marcus, Ronit, Itzhaki, Orit, Yerushalmi, Ronit, Shem-Tov, Noga, Sdayoor, Inbal, Shouval, Roni, Jacoby, Elad, Kedmi, Meirav, Nagler, Arnon, Shimoni, Avichai, Avigdor, Abraham

“…Background Tisagenlecleucel and brexucabtagene autoleucel have demonstrated remarkable efficacy and safety results in adult patients with relapsed/ refractory…”
Get full text

Pre-Treatment Pulmonary Assessment Have Limited Utility in B-Cell Lymphoma Patients Treated with Autologous Anti-CD19 CAR T-Cell Therapy by Sdayoor, Inbal, Shouval, Roni, Fried, Shalev, Marcus, Ronit, Danylesko, Ivetta, Yerushalmi, Ronit, Shem-Tov, Noga, Itzhaki, Orit, Jacoby, Elad, Kedmi, Meirav, Nagler, Arnon, Shimoni, Avichai, Segel, Michael J, Avigdor, Abraham

“…Introduction Pulmonary function tests (PFT) play a pivotal role in hematopoietic cell transplantation (HCT), with routine evaluation in HCT candidates…”
Get full text

Point-of-care anti-CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory follicular lymphoma by Fried, Shalev, Shkury, Eden, Itzhaki, Orit, Sdayoor, Inbal, Yerushalmi, Ronit, Shem-Tov, Noga, Danylesko, Ivetta, Jacoby, Elad, Shouval, Roni, Kedmi, Meirav, Marcus, Ronit, Nagler, Arnon, Shimoni, Avichai, Avigdor, Abraham

“…Patients with relapsed/refractory follicular lymphoma (R/R-FL) often require multiple treatment lines. We performed a phase 1b/2 single-center clinical trial…”
Get full text

The Impact of Cardiovascular Vulnerabilities in Non Hodgkin Lymphoma Patients Treated with Chimeric Antigen Receptor T Cell Therapy by Landego, Ivan, Flynn, Jessica R, Goldman, Adam, Devlin, Sean M., Luttwak, Efrat, Luna De Abia, Alejandro, Corona, Magdalena, Kedmi, Meirav, Sdayoor, Inbal, Fried, Shalev, Shem-Tov, Noga, Shimoni, Avichai, Danylesko, Ivetta, Hammoud, Mohammad, Yerushalmi, Ronit, Nagler, Arnon, Marcus, Ronit, El-Moghraby, Ahmed, Rehman, Mahin, Dahi, Parastoo B., Giralt, Sergio A., Lin, Richard J., Palomba, Maria Lia, Scordo, Michael, Shah, Gunjan L., Perales, Miguel-Angel, Mahmood, Syed, Avigdor, Abraham, Liu, Jennifer, Shouval, Roni

“…INTRODUCTION: CAR-T therapy is an effective treatment for hematological malignancies. However, in recent years there is a growing body of literature suggesting…”
Get full text

Response Rates of Extra-Nodal Diffuse Large B Cell Lymphoma to CD19-CAR T Cells - a Real Word Retrospective Multi-Center Study by Beyar Katz, Ofrat, Perry, Chava, Luttwak, Efrat, Sdayoor, Inbal, Bar-On, Yael, Amit, Odelia, Gold, Ronit, Herishanu, Yair, Benyamini, Noam, Grisariu Greenzaid, Sigal, Avni, Batia, Stepensky, Polina, Libster, Diana, Yehudai-Ofir, Dana, Harlev, Shimrit, Sharvit, Liat, Zuckerman, Tsila, Greenbaum, Uri, Avivi, Irit, Ram, Ron

Get full text

Response rates of extra‐nodal diffuse large B cell lymphoma to anti‐CD19‐CAR T cells: A real word retrospective multicenter study by Beyar Katz, Ofrat, Perry, Chava, Grisariu‐Greenzaid, Sigal, Yehudai‐Ofir, Dana, Luttwak, Efrat, Avni, Batia, Zuckerman, Tsila, Sdayoor, Inbal, Stepensky, Polina, Ringelstein‐Harlev, Shimrit, Bar‐On, Yael, Libster, Diana, Sharvit, Liat, Amit, Odelia, Greenbaum, Uri, Gold, Ronit, Herishanu, Yair, Benyamini, Noam, Avivi, Irit, Ram, Ron

“…Chimeric antigen receptor T‐cells (CAR‐T) are widely used for the treatment of relapsed/refractory diffuse large B cell lymphoma (DLBCL). The data for CAR‐T…”
Get full text

Early Versus Late CAR-T Therapy in Large B-Cell Lymphoma: Real-World Outcomes by Corona, Magdalena, de Abia, Alejandro Luna, Flynn, Jessica, Sdayoor, Inbal, Fried, Shalev, Devlin, Sean M., Landego, Ivan, Kedmi, Meirav, Shem-Tov, Noga, Shimoni, Avichai, Danylesko, Ivetta, Yerushalmi, Ronit, Marcus, Ronit, Dahi, Parastoo B., Lin, Dr. Richard J., Palomba, M. Lia, Park, Jae H., Salles, Gilles, Nagler, Arnon, Shah, Gunjan L., Avigdor, Abraham, Perales, Miguel-Angel, Shouval, Roni

“…Recent randomized controlled trials have established CD19-chimeric antigen receptor T-cell (CAR-T) therapy as second-line treatment in large B-cell lymphoma…”
Get full text